Xie M - Search Results

1

Serum cytokine analysis in a cohort of advanced non-small cell lung cancer treated with PD-1 inhibitors reveals predictive markers of CXCL12.

Xu Y, Ding L, Li H, Peng Z, Ding K, Huang Z, Zhou Z, Xie M, Yan J, Feng S, Fan Y. Xu Y, et al. Among authors: xie m. Front Immunol. 2023 Jun 9;14:1194123. doi: 10.3389/fimmu.2023.1194123. eCollection 2023. Front Immunol. 2023. PMID: 37359565 Free PMC article.

2

KRAS-Mutant Non-Small Cell Lung Cancer: An Emerging Promisingly Treatable Subgroup.

Xie M, Xu X, Fan Y. Xie M, et al. Front Oncol. 2021 May 3;11:672612. doi: 10.3389/fonc.2021.672612. eCollection 2021. Front Oncol. 2021. PMID: 34012925 Free PMC article. Review.

3

Efficacy of PD-1/PD-L1 inhibitors in patients with non-small cell lung cancer and brain metastases: A real-world retrospective study in China.

Sheng J, Li H, Yu X, Yu S, Chen K, Pan G, Xie M, Li N, Zhou Z, Fan Y. Sheng J, et al. Among authors: xie m. Thorac Cancer. 2021 Nov;12(22):3019-3031. doi: 10.1111/1759-7714.14171. Epub 2021 Oct 1. Thorac Cancer. 2021. PMID: 34596346 Free PMC article.

4

The Novel Tumor Microenvironment-Related Prognostic Gene AIF1 May Influence Immune Infiltrates and is Correlated with TIGIT in Esophageal Cancer.

Xu X, Wang D, Li N, Sheng J, Xie M, Zhou Z, Cheng G, Fan Y. Xu X, et al. Among authors: xie m. Ann Surg Oncol. 2022 May;29(5):2930-2940. doi: 10.1245/s10434-021-10928-9. Epub 2021 Nov 9. Ann Surg Oncol. 2022. PMID: 34751872

5

ASO Author Reflection: The TME-Related Gene AIF1 Signature Predicts Esophageal Carcinoma Prognosis.

Xu X, Wang D, Li N, Sheng J, Xie M, Zhou Z, Cheng G, Fan Y. Xu X, et al. Among authors: xie m. Ann Surg Oncol. 2022 May;29(5):2941. doi: 10.1245/s10434-021-10955-6. Epub 2022 Feb 15. Ann Surg Oncol. 2022. PMID: 35169974 No abstract available.

6

Real-world utilization of PD-1/PD-L1 inhibitors with palliative radiotherapy in patients with metastatic non-small cell lung cancer.

Zhou ZC, Chen KY, Li N, Xie MY, Sheng JM, Fan Y, Huang ZY. Zhou ZC, et al. Thorac Cancer. 2022 Aug;13(16):2291-2300. doi: 10.1111/1759-7714.14553. Epub 2022 Jun 28. Thorac Cancer. 2022. PMID: 35762488 Free PMC article.

7

The Efficacy of PD-1/PD-L1 Inhibitors in Patients with Liver Metastasis of Non-Small Cell Lung Cancer: A Real-World Study.

Xie M, Li N, Xu X, Xu Y, Li H, Zhu L, Sheng J, Zhou Z, Fan Y. Xie M, et al. Cancers (Basel). 2022 Sep 5;14(17):4333. doi: 10.3390/cancers14174333. Cancers (Basel). 2022. PMID: 36077868 Free PMC article.

8

Real-world treatment and prognostic factors for survival in ALK+ non-small cell lung cancer (NSCLC) patients with brain metastases in China.

Li N, Xie M, Zhou Z, Sheng J, Yu X, Fan Y. Li N, et al. Among authors: xie m. Thorac Cancer. 2023 Jan;14(3):237-245. doi: 10.1111/1759-7714.14739. Epub 2022 Nov 21. Thorac Cancer. 2023. PMID: 36411716 Free PMC article.

9

LncRNAs and related molecular basis in malignant pleural mesothelioma: Challenges and potential.

Xu X, Li H, Xie M, Zhou Z, Wang D, Mao W. Xu X, et al. Among authors: xie m. Crit Rev Oncol Hematol. 2023 Jun;186:104012. doi: 10.1016/j.critrevonc.2023.104012. Epub 2023 Apr 26. Crit Rev Oncol Hematol. 2023. PMID: 37116816 Review.

10

Efficacy of immunotherapy in RET fusion-positive NSCLC: A meta-analysis.

Peng Z, Ding K, Xie M, Xu Y. Peng Z, et al. Among authors: xie m. Heliyon. 2024 Jul 18;10(14):e34626. doi: 10.1016/j.heliyon.2024.e34626. eCollection 2024 Jul 30. Heliyon. 2024. PMID: 39149080 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,927 results

Search Page

Filters